2 unknown, 1 completed, 1 recruiting. 3 Phase 2, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Completed 1 |
| Early Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Donor Lymphocyte Infusion: new trials by email Literature Review of Donor Lymphocyte Infusion trials Research Report on Donor Lymphocyte Infusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies Prophylactic DLI - Donor Lymphocyte Infusion, Peripheral Blood Stem Cell Transplantation | Phase 2 | Unknown | Chinese PLA General Hospital | 40 | 2019-01-01 | 2018-12-13 |
| Exercise as an Immune Adjuvant for Allogeneic Cell Therapies Exercise, Isoproterenol, Placebo - Leukemia, Hematopoetic Stem Cell Transplantation | Early Phase 1 | Recruiting | University of Arizona | 200 | 2018-01-24 | 2026-06-05 |
| Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant donor lymphocyte infusion - Donor Lymphocyte Infusion, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2 | Unknown | Peking University People's Hospital | 40 | 2017-03-01 | 2020-03-10 |
| MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT donor lymphocyte infusion - Minimal Residual Disease, Donor Lymphocyte Infusion | Phase 2 / Phase 3 | Completed | Nanfang Hospital, Southern Medical University | 206 | 2016-01-01 | 2020-02-25 |
Recurrence (3) · Graft vs Host Disease (2) · Neoplasm, Residual (2) · Leukemia (1) · Lymphoma (1) · Motor Activity (1)
Disease Attributes (3) · Immune System Diseases (3) · Neoplasms (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Neoplastic Processes (2) · Behavior (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms by Histologic Type (1)
Bisoprolol (1) · Carvedilol (1) · Decitabine (1) · Drug Therapy (1) · Exercise (1) · Isoproterenol (1) · Nadolol (1) · Roflumilast (1) · Tablets (1)
Chinese PLA General Hospital (1) · Nanfang Hospital, Southern Medical University (1) · Peking University People's Hospital (1) · University of Arizona (1)
China (3) · United States (1)
Qifa Liu (1) · Xiao-jun Huang (1)
PMID 32164760, PMID 35467818, PMID 36189306, PMID 36719647, PMID 37077913, PMID 38592213, PMID 40311885, PMID 40574863, PMID 40940923, PMID 41194247, PMID 41538301, PMID 41776652, PMID 42845554
R01CA277493 (1)